论文部分内容阅读
目的：观察联用黄芪注射液和蝮蛇抗栓酶治疗急性脑梗死的疗效。方法：治疗组３０例患者采用黄芪注射液和蝮蛇抗栓酶治疗；对照组３０例用低分子右旋糖酐加丹参注射液治疗。２组患者对症处理相同，比较２组疗效和２组患者治疗前后血液流变性的变化。结果：治疗组基本治愈率６３．３％，总有效率９３．３％；对照组分别为２６．７％和７３．３％，治疗组基本治愈率和总有效率均显著优于对照组（Ｐ＜０．０１和Ｐ＜０．０５）。治疗后治疗组血液流变学指标的改善亦均优于对照组（Ｐ均＜０．０５）。结论：联用黄芪注射液和蝮蛇抗栓酶治疗中老年急性脑梗死早期见效快，作用稳定，无明显不良反应，值得临床推广。
Objective: To observe the curative effect of combining astragalus injection and viper antithrombotic enzyme on acute cerebral infarction. Methods: Thirty patients in the treatment group were treated with astragalus injection and viper snake antithrombin; in the control group, 30 cases were treated with low molecular dextran plus salvia miltiorrhiza injection. Two groups of patients symptomatic treatment the same, the efficacy of two groups were compared and two groups of patients before and after treatment of hemorheology changes. Results: The cure rate was 63.3% and the total effective rate was 93.3% in the treatment group and 26.7% and 73.3% in the control group respectively. The cure rate and total effective rate in the treatment group were significantly better than those in the control group P <0.01 and P <0.05). After treatment, the improvement of hemorrheological indexes in the treatment group was also better than that in the control group (all P <0.05). Conclusion: Astragalus injection combined with viper snake antithrombin in the treatment of middle-aged and elderly patients with acute cerebral infarction in the early quick, stable, no obvious adverse reactions, is worth clinical promotion.